Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hass

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Anticancer Research|July 31, 2020
Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common CancersConstanze Heinze, Jazan Omari, Robert Damm, et al.
Anticancer Research|May 17, 2019
Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial BrachytherapyJazan Omari, Constanze Heinze, Robert Damm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 25, 2018
Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 casesMaciej Powerski, Susanne Penzlin, Peter Hass, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2016
Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factorsKonrad Mohnike, Steffen Wolf, Robert Damm, et al.
Plos One|November 14, 2014
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicityMax Seidensticker, Ricarda Seidensticker, Robert Damm, et al.
EJNMMI Research|May 21, 2015
The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastasesJulian Mm Rogasch, Ingo G Steffen, Frank Hofheinz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2017
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II studyThomas Kuhnt, Andreas Schreiber, Anett Pirnasch, et al.
Brachytherapy|January 25, 2023
Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodulesConstanze Heinze, Robert Damm, Max Othmer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2015
Accuracy of applicator tip reconstruction in MRI-guided interstitial 192Ir-high-dose-rate brachytherapy of liver tumorsChristian Wybranski, Benjamin Eberhardt, Katharina Fischbach, et al.
Brachytherapy|September 17, 2019
Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignanciesPeter Hass, Konrad Mohnike, Siegfried Kropf, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Anticancer Research|July 31, 2020
Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common CancersConstanze Heinze, Jazan Omari, Robert Damm, et al.
Anticancer Research|May 17, 2019
Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial BrachytherapyJazan Omari, Constanze Heinze, Robert Damm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 25, 2018
Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 casesMaciej Powerski, Susanne Penzlin, Peter Hass, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2016
Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factorsKonrad Mohnike, Steffen Wolf, Robert Damm, et al.
Plos One|November 14, 2014
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicityMax Seidensticker, Ricarda Seidensticker, Robert Damm, et al.
EJNMMI Research|May 21, 2015
The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastasesJulian Mm Rogasch, Ingo G Steffen, Frank Hofheinz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2017
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II studyThomas Kuhnt, Andreas Schreiber, Anett Pirnasch, et al.
Brachytherapy|January 25, 2023
Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodulesConstanze Heinze, Robert Damm, Max Othmer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2015
Accuracy of applicator tip reconstruction in MRI-guided interstitial 192Ir-high-dose-rate brachytherapy of liver tumorsChristian Wybranski, Benjamin Eberhardt, Katharina Fischbach, et al.
Brachytherapy|September 17, 2019
Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignanciesPeter Hass, Konrad Mohnike, Siegfried Kropf, et al.
Pageof 6